Zhongzhi Pharmaceutical Holdings Limited
HKSE 3737.HK
Zhongzhi Pharmaceutical Holdings Limited Price to Book Ratio (P/B) on January 27, 2025: 0.75
-
Zhongzhi Pharmaceutical Holdings Limited 52-week high Price to Book Ratio (P/B) is 0.80 on January 16, 2025, which is 6.09% above the current Price to Book Ratio (P/B).
-
Zhongzhi Pharmaceutical Holdings Limited 52-week low Price to Book Ratio (P/B) is 0.71 on January 20, 2025, which is -4.90% below the current Price to Book Ratio (P/B).
-
Zhongzhi Pharmaceutical Holdings Limited average Price to Book Ratio (P/B) for the last 52 weeks is 0.75.
| Date | Price to Book Ratio (P/B) | Dividend Yield | Free Cash Flow Yield | Price to Earnings Ratio (P/E) |
|---|
Don’t Miss A Beat
| CEO | Mr. Zhi Tian Lai |
| IPO Date | July 13, 2015 |
| Location | China |
| Headquarters | No. 3 Kangtai Road South |
| Employees | 2,736 |
| Sector | Healthcare |
| Industries | |
Zhongzhi Pharmaceutical Holdings Limited, an investment holding company, engages in the research, development, manufacture, and sale of pharmaceutical products in the People's Republic of China. The company operates through three segments: Pharmaceutical Manufacturing, Operation of Chain Pharmacies, and Operation of On-Line Pharmacies. It provides Chinese patent medicines and decoction pieces under the Zeus, Liumian, and Caojinghua brands. The company is also manufacture and sale of food and Chinese herbs; property management; and pharmaceutical drugs, as well as offers detection and testing services. As of December 31, 2021, it operated 398 self-operated chain pharmacies, including 361 medical insurance designated pharmacies located in Zhongshan in the Guangdong Province under the Zeus brand. The company was founded in 1993 and is headquartered in Zhongshan, the People's Republic of China. Zhongzhi Pharmaceutical Holdings Limited is a subsidiary of Crystal Talent Investment Group Limited.
Past 5 years
USD 1.10
StockViz Staff
February 2, 2025
Any question? Send us an email